Therapeutic targeting TLR3 by the combination of TLR3 ligand, Poly(I:C) and an IAPs antagonist, Smac mimetic to induce cell death and modulate invasion were also investigated in CCA cells. Here, TLR3 is linked to cholangiocarcinoma.